Yes — in the UK you can usually take Mounjaro (tirzepatide) after gastric sleeve or gastric bypass surgery, provided a GPhC-registered prescriber assesses you as clinically suitable. Previous bariatric surgery does not, on its own, rule you out.
This article explains why post-surgical patients often ask about Mounjaro, how having had a sleeve or bypass affects the assessment, and what to expect from an online consultation.
The short answer
Having had a gastric sleeve or Roux-en-Y bypass is not an automatic barrier to weight-loss medication in the UK. Prescribers used to treat prior bariatric surgery cautiously, but current practice is to assess it case by case rather than as a blanket exclusion.
What matters is the standard eligibility framework, your current health, and an honest conversation about how your altered anatomy might affect side effects and monitoring. The decision always rests with the prescriber after a free online consultation.
Why people ask about Mounjaro after surgery
Bariatric surgery is an effective long-term treatment, but some people experience weight regain in the years afterwards, or find their weight loss plateaus above their goal. That is common and does not mean the surgery "failed".
Because Mounjaro works through appetite-regulating gut hormones rather than by restricting stomach size, some post-surgical patients and their clinicians consider it as an additional tool. It is not a replacement for the lifestyle habits built after surgery — it is used alongside them.
How Mounjaro works differently from surgery
Mounjaro activates two gut-hormone receptors — GLP-1 and GIP — at the same time. This reduces appetite, slows how quickly the stomach empties and helps you feel fuller for longer.
Surgery physically changes your digestive tract; Mounjaro changes the hormonal signals that drive hunger. The two mechanisms are different, which is part of why the medication can still have an effect after an operation.
Do you meet the eligibility criteria?
The same UK eligibility rules apply whether or not you have had surgery. In broad terms you may be considered if you are:
- Aged 18 or over, and
- Have a BMI of 30 or more, or
- Have a BMI of 27–30 with a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea.
An important practical point for post-surgical patients: your BMI is calculated on your current weight, not your pre-surgery weight. If surgery brought your BMI well below the threshold, you may no longer meet the criteria — and that is a good outcome.
When it is not suitable
Regardless of surgical history, Mounjaro is not suitable if you are pregnant, planning pregnancy or breastfeeding, have type 1 diabetes, a personal or family history of medullary thyroid cancer or MEN2, a history of pancreatitis, severe gastrointestinal disease, an active eating disorder, severe liver or kidney impairment, or a known allergy to tirzepatide.
A history of pancreatitis and severe GI disease are especially relevant to flag after surgery, so be thorough in your consultation answers.
What your prescriber will want to know
Because your anatomy has changed, an online prescriber will typically ask for more detail than usual. Be ready to share:
- Which operation you had — sleeve gastrectomy, gastric bypass, gastric band or another procedure — and roughly when.
- Your weight history — your lowest weight after surgery, your current weight, and any regain.
- Ongoing symptoms — reflux, dumping syndrome, nausea or difficulty tolerating certain foods.
- Nutritional status and supplements — many post-bariatric patients take vitamins and minerals long term.
- Whether you are still under a bariatric team, so care can be coordinated.
This is why the process includes a review of your answers by a registered prescriber and, where clinically needed, a short video consultation.
Side effects to consider after surgery
The common side effects of Mounjaro (affecting more than 1 in 10 people) are gastrointestinal: nausea, vomiting, diarrhoea, constipation, decreased appetite and fatigue. These usually ease as your body adjusts and are managed by titrating the dose slowly.
After a sleeve or bypass, your gut may already be more sensitive to how quickly food moves through it. This is one reason prescribers start at the lowest 2.5mg dose and increase gradually — 5mg, 7.5mg, 10mg, 12.5mg, up to a maximum of 15mg — only when each step is tolerated.
Rare but serious risks include severe allergic reaction, acute pancreatitis, severe hypoglycaemia (particularly if you take diabetes medication), severe GI disease and worsening diabetic retinopathy. If you experience any side effect, you can report it through the MHRA Yellow Card scheme at https://yellowcard.mhra.gov.uk/.
What results are realistic?
The headline trial figure comes from people who had not had bariatric surgery. In the SURMOUNT-1 trial, participants on the 15mg dose lost on average 22.5% of body weight over 72 weeks, alongside lifestyle support. Individual results vary; not everyone reaches this.
If you have already lost significant weight through surgery, your starting point is different, and your response may not mirror the trial. The goal for many post-surgical patients is addressing regain or a plateau rather than repeating a large first-time loss.
Mounjaro versus other options
Mounjaro is one of several licensed treatments. Others include the Wegovy injection (semaglutide), the once-daily Wegovy Tablet, and Foundayo (orforglipron). You can compare the full range on our treatments overview or the combined weight-loss injections page.
| Feature | Detail |
|---|---|
| Mechanism | Dual GLP-1 and GIP receptor activation |
| How taken | Weekly self-injection |
| Dose range | 2.5mg starter up to 15mg maximum |
| Price from | £160/month (2.5mg) |
Which one — if any — is right for you is a clinical decision, not a self-diagnosis. Your surgical history is one of the factors the prescriber weighs up.
How to start
The process is straightforward and the consultation is free. You only pay if a treatment is prescribed and you choose to go ahead.
- Complete a free online consultation, including full details of your surgery.
- A GPhC-registered prescriber reviews your answers to check treatment is clinically appropriate and safe.
- A short video consultation takes place where clinically needed.
- If suitable, the medicine is dispensed by our own UK pharmacy and sent by tracked delivery, with ongoing prescriber support.
A prescription is only issued if it is clinically appropriate — treatment is never guaranteed. You can read more about our regulated process on our about page or get in touch via contact us.
This article is for information only and is not a substitute for personalised medical advice. Weight-loss medicines are prescription-only, are not suitable for everyone, and are prescribed only after a clinical consultation with a GPhC-registered prescriber. Individual results vary. Always speak to a UK-registered pharmacist or doctor before starting or changing any prescription medication.
